eISSN 2329-0358


Get your full text copy in PDF

Characterization of Patient Antibodies after Kidney Transplantation

A Slavcev

Ann Transplant 2001; 6(2): 12-15

ID: 497583

Objective: The aim of this study was to characterize patient antibodies before and after cadaver and/or living-donor kidney transplantation and to correlate these data with the clinical course after transplantation. Methods: Sera from 69 cadaver, -9 living-related and 2 patients waiting for living-donor kidney transplantation were analyzed by the complement dependent cytotoxicity (CDq test, flow cytometry (FCXM) and ELISA. Results: FCXM revealed that 15.0% of patients before transplantation and 16.7% after transplantation had antibodies to donor cells. 10.3% patients were positive before and after transplantation (+/ +), while 6.8% developed antibodies early after transplantation (-/ +). Analysis of the specificity of those antibodies by ELISAshowed that it was directed to: I) mismatched donor HLAantigens 2) antigens belonging to the same cross-reacting group (CREG) as the mismatched donor antigens 3) HLAantigens not expressed by donor cells or, probably, to non-HLA antigens. Conclusion:Anti-HLA antibodies were detected in patients before and after transplantation and in most cases their anti-HLA specificity could be determined. Fast and precise characterization of antibodies in patients before and after transplantation can be performed by both sensitive methods - FCXM and ELISA - which may help predict the onset of immunological complications and, consequently, improve the prognosis after organ transplantation.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree